MX2010005057A - Metodos y composiciones para uso de diagnostico en pacientes de cancer. - Google Patents
Metodos y composiciones para uso de diagnostico en pacientes de cancer.Info
- Publication number
- MX2010005057A MX2010005057A MX2010005057A MX2010005057A MX2010005057A MX 2010005057 A MX2010005057 A MX 2010005057A MX 2010005057 A MX2010005057 A MX 2010005057A MX 2010005057 A MX2010005057 A MX 2010005057A MX 2010005057 A MX2010005057 A MX 2010005057A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- cancer patients
- diagnostic use
- cancer
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98688407P | 2007-11-09 | 2007-11-09 | |
| PCT/US2008/082456 WO2009061800A2 (en) | 2007-11-09 | 2008-11-05 | Methods and compositions for diagnostic use in cancer patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010005057A true MX2010005057A (es) | 2010-05-19 |
Family
ID=40342593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010005057A MX2010005057A (es) | 2007-11-09 | 2008-11-05 | Metodos y composiciones para uso de diagnostico en pacientes de cancer. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20090123930A1 (enExample) |
| EP (1) | EP2222874A2 (enExample) |
| JP (1) | JP2011502513A (enExample) |
| KR (1) | KR20100095571A (enExample) |
| CN (1) | CN101910416A (enExample) |
| AU (1) | AU2008324782A1 (enExample) |
| BR (1) | BRPI0817158A2 (enExample) |
| CA (1) | CA2703258A1 (enExample) |
| IL (1) | IL205246A0 (enExample) |
| MX (1) | MX2010005057A (enExample) |
| RU (1) | RU2010123381A (enExample) |
| WO (1) | WO2009061800A2 (enExample) |
| ZA (1) | ZA201002808B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG177640A1 (en) * | 2009-07-13 | 2012-02-28 | Genentech Inc | Diagnostic methods and compositions for treatment of cancer |
| KR101557545B1 (ko) * | 2009-09-17 | 2015-10-06 | 에프. 호프만-라 로슈 아게 | 암 환자에서 진단 용도를 위한 방법 및 조성물 |
| CN104634971A (zh) * | 2010-07-19 | 2015-05-20 | 霍夫曼-拉罗奇有限公司 | 鉴定响应抗癌疗法的可能性升高的患者的方法 |
| WO2012010549A1 (en) * | 2010-07-19 | 2012-01-26 | F. Hoffmann-La Roche Ag | Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| US10260097B2 (en) | 2011-06-02 | 2019-04-16 | Almac Diagnostics Limited | Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent |
| CA2862835A1 (en) * | 2012-01-13 | 2013-07-18 | Genentech, Inc. | Biological markers for identifying patients for treatment with vegf antagonists |
| WO2014001232A1 (en) * | 2012-06-26 | 2014-01-03 | F. Hoffmann-La Roche Ag | Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| HK1214633A1 (zh) * | 2012-12-03 | 2016-07-29 | Almac Diagnostics Limited | 癌症的分子诊断测试 |
| US11015190B2 (en) | 2013-09-17 | 2021-05-25 | Lucence Life Sciences Pte Ltd | Method of treating a patient having renal cancer |
| GB201409479D0 (en) * | 2014-05-28 | 2014-07-09 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
| MX2017007535A (es) * | 2014-12-09 | 2017-08-10 | Merck Sharp & Dohme | Sistema y metodos para derivar biomarcadores de firmas geneticas de la respuesta a antagonistas de muerte programada 1 (pd-1). |
| KR101903522B1 (ko) * | 2015-11-25 | 2018-11-23 | 한국전자통신연구원 | 다차원 건강데이터에 대한 유사사례 검색 방법 및 그 장치 |
| WO2025098316A1 (en) * | 2023-11-09 | 2025-05-15 | Sun Jet Biotechnology Inc. | Apolipoprotein a-ii biomarkers for detecting and monitoring cancers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030027216A1 (en) * | 2001-07-02 | 2003-02-06 | Kiernan Urban A. | Analysis of proteins from biological fluids using mass spectrometric immunoassay |
| EP1869216B1 (en) * | 2005-04-13 | 2012-08-15 | Oncotest GmbH | Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds |
| WO2007123722A2 (en) * | 2006-03-31 | 2007-11-01 | Bayer Healthcare Llc | Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
-
2008
- 2008-11-05 WO PCT/US2008/082456 patent/WO2009061800A2/en not_active Ceased
- 2008-11-05 KR KR1020107012551A patent/KR20100095571A/ko not_active Withdrawn
- 2008-11-05 BR BRPI0817158 patent/BRPI0817158A2/pt not_active IP Right Cessation
- 2008-11-05 AU AU2008324782A patent/AU2008324782A1/en not_active Abandoned
- 2008-11-05 JP JP2010533204A patent/JP2011502513A/ja not_active Withdrawn
- 2008-11-05 EP EP08846956A patent/EP2222874A2/en not_active Withdrawn
- 2008-11-05 RU RU2010123381/15A patent/RU2010123381A/ru not_active Application Discontinuation
- 2008-11-05 US US12/265,143 patent/US20090123930A1/en not_active Abandoned
- 2008-11-05 CN CN2008801243215A patent/CN101910416A/zh active Pending
- 2008-11-05 MX MX2010005057A patent/MX2010005057A/es not_active Application Discontinuation
- 2008-11-05 CA CA2703258A patent/CA2703258A1/en not_active Abandoned
-
2010
- 2010-04-21 ZA ZA2010/02808A patent/ZA201002808B/en unknown
- 2010-04-22 IL IL205246A patent/IL205246A0/en unknown
- 2010-11-19 US US12/950,824 patent/US20110151468A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011502513A (ja) | 2011-01-27 |
| RU2010123381A (ru) | 2011-12-20 |
| IL205246A0 (en) | 2010-12-30 |
| WO2009061800A3 (en) | 2009-07-16 |
| ZA201002808B (en) | 2011-07-27 |
| US20090123930A1 (en) | 2009-05-14 |
| BRPI0817158A2 (pt) | 2015-04-14 |
| US20110151468A1 (en) | 2011-06-23 |
| CA2703258A1 (en) | 2009-05-14 |
| AU2008324782A1 (en) | 2009-05-14 |
| CN101910416A (zh) | 2010-12-08 |
| WO2009061800A2 (en) | 2009-05-14 |
| EP2222874A2 (en) | 2010-09-01 |
| KR20100095571A (ko) | 2010-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009061800A3 (en) | Methods and compositions for diagnostic use in cancer patients | |
| MX2018011832A (es) | Metodos y composiciones para uso en diagnostico de pacientes con cancer. | |
| PT3130923T (pt) | Métodos terapêuticos relacionados com células estaminais | |
| MX2012002909A (es) | Metodos y composiciones para su uso en diagnostico de pacientes con cancer. | |
| IL190733A0 (en) | Methods and compositions for use in treatment of patients with autoantibody positive diseases | |
| GB0708761D0 (en) | Improvements in and relating to medical instruments | |
| MX2019000225A (es) | Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades. | |
| GB2467467C (en) | TAZ/WWTR1 for diagnosis and treatment of cancer | |
| MY160041A (en) | Compositions and methods for treating parasitic infections | |
| IL206079A0 (en) | Microrna expression profiling and targeting in peripheral blood in lung cancer | |
| GB0920703D0 (en) | Compositions containing satiogens and methods of use | |
| PH12012501067A1 (en) | Combination therapy for treating cancer and diagnostic assays for use therein | |
| IL206748A (en) | Molecular test for @cancer @ breast cancer @ | |
| PT2282758T (pt) | Anticorpos e vacinas para uso em métodos terapêuticos e diagnósticos para perturbações relacionadas com a alfa-sinucleína | |
| MX2009010066A (es) | Composiciones y metodos para la ablacion especifica de la evasion mutacional de terapias especificas para cancer. | |
| WO2012006421A3 (en) | Diagnosis and treatment of breast cancer | |
| EP2614375A4 (en) | COMBINATION METHOD FOR CANCER DIAGNOSIS | |
| NZ584606A (en) | An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases | |
| WO2010054377A3 (en) | Fully human antibodies against n-cadherin | |
| MX2013003599A (es) | Interferon-beta para uso como monoterapia o en combinacion con otras terapias de cancer. | |
| PT2320900T (pt) | Utilização de opioides ou miméticos de opioides para o tratamento de pacientes com cancros resistentes | |
| IL217209A0 (en) | Novel antibodies and their uses in therapeutic and diagnostic methods | |
| GB2465907A (en) | VHZ for diagnosis and treatment of cancer | |
| PL2291657T3 (pl) | Stężenie heterotrimerów blys/april w surowicy oraz zastosowanie w sposobach diagnostycznych | |
| UA95956C2 (uk) | Набір для визначення mage-а3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |